Mar 10, 2026

Email 1:

Subject: Generic Ozempic could be made for just $3 a month, researchers say

Content:

– Novo Nordisk is reducing list prices for Ozempic and Wegovy by half next year, but the drugs remain unaffordable for many.

– Analysis shows generic semaglutide drugs could be produced for as low as $28 per year starting this month in countries like India and China.

– This could make treatment accessible for people with obesity and type 2 diabetes who currently face high costs.

– Also featured: The controversy and challenges surrounding FDA advisory committee meetings under former head Vinay Prasad, autism diagnosis trends linked to insurance coverage for applied behavioral analysis (ABA), and community protests against corporate takeovers of Oregon hospitals.

Email 2:

Subject: 🧑‍💻 Foiling health hackss

Content:

– Congress is advancing bipartisan legislation to improve cybersecurity in healthcare after the 2024 Change Healthcare cyberattack.

– The bill focuses on improved government coordination, incident response plans, cybersecurity grants, and multi-factor authentication.

– FDA Center for Biologics Evaluation and Research Director Vinay Prasad will depart by the end of April amid controversies over vaccine approvals and workplace complaints.

– Prasad’s exit may reduce regulatory uncertainty for biotech companies.

– Additional topics include states with highly concentrated hospital markets impacting patient choice and a lawsuit demanding transparency on Medicare benefit cuts for some immigrants.

Email 3:

Subject: Protein folding caught in real time

Content:

– Researchers have directly measured how long individual proteins take to fold, discovering no link between folding time and protein size or sequence.

– Proteins fold more efficiently compared to other biomolecules like DNA.

– Other news: accelerated global warming rates since 2015, a groundbreaking case connecting a man to a genetically modified pig liver to sustain him while awaiting transplant, and the role of AI in modern warfare.

– Features also cover concerns about federal science governance in the US and advice on avoiding common PhD application mistakes.

Email 4:

Subject: Don’t miss us in NYC and San Diegos

Content:

– STAT+ subscribers gain exclusive benefits like 40% discounts on passes to the Breakthrough Summit East in NYC and 20% off STAT Reports.

– Upcoming events include a March NYC Summit highlighting innovations in health, biotech, and academia, plus a deep dive oncology event in San Diego.

– Subscriber-only stories spotlight challenges such as Vertex’s CRISPR treatment setbacks for sickle cell disease, the FDA overruling staff to reject Moderna’s flu vaccine application, and a failed key study for a cancer detection test by Grail.

Stay Well!